Skip to content

Opening book details…

About this Medicine article

Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial by Wademan, D. T.; Busakwe, L.; Nicholson, T. J.; van der Zalm, M.; Palmer, M.; Workman, J.; Turkova, A.; Crook, A. M.; Thomason, J.; Gibb, D. M.; Seeley, J.; Hesseling, A.; Hoddinott, G.; on behalf of the SHINE trial team, is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Wademan, D. T.; Busakwe, L.; Nicholson, T. J.; van der Zalm, M.; Palmer, M.; Workman, J.; Turkova, A.; Crook, A. M.; Thomason, J.; Gibb, D. M.; Seeley, J.; Hesseling, A.; Hoddinott, G.; on behalf of the SHINE trial team,
Publisher
The International Union Against Tuberculosis & Lung Disease; International Union Against Tuberculosis and Lung Disease; International Union Against Tuberculosis And Lung Disease/Union Internationale Contre la Tuberculose et les Maladies Respiratories (ISSN 1027-3719)
Published
2019
Field
Medicine (Health Sciences)

More by Wademan, D. T.; Busakwe, L.; Nicholson, T. J.; van der Zalm, M.; Palmer, M.; Workman, J.; Turkova, A.; Crook, A. M.; Thomason, J.; Gibb, D. M.; Seeley, J.; Hesseling, A.; Hoddinott, G.; on behalf of the SHINE trial team,

Browse all works by Wademan, D. T.; Busakwe, L.; Nicholson, T. J.; van der Zalm, M.; Palmer, M.; Workman, J.; Turkova, A.; Crook, A. M.; Thomason, J.; Gibb, D. M.; Seeley, J.; Hesseling, A.; Hoddinott, G.; on behalf of the SHINE trial team,